Adverum Biotechnologies' Series A - II Round

Adverum Biotechnologies raised a round of funding on November 23, 2013.

Adverum Biotechnologies, formerly Avalanche Biotechnologies, is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.…

Articles about Adverum Biotechnologies' Series A - II Round: